254 related articles for article (PubMed ID: 32077315)
21. Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease.
Yilmaz MI; Siriopol D; Saglam M; Kurt YG; Unal HU; Eyileten T; Gok M; Cetinkaya H; Oguz Y; Sari S; Vural A; Mititiuc I; Covic A; Kanbay M
Kidney Int; 2014 Dec; 86(6):1213-20. PubMed ID: 24988065
[TBL] [Abstract][Full Text] [Related]
22. Endothelium biomarkers endocan and thrombomodulin levels in isolated coronary artery ectasia.
Baysal SS; Koç Ş; Güneş A; Altiparmak IH
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4677-4682. PubMed ID: 30058709
[TBL] [Abstract][Full Text] [Related]
23. Levels of Endocan, Angiopoietin-2, and Hypoxia-Inducible Factor-1a in Patients with Autosomal Dominant Polycystic Kidney Disease and Different Levels of Renal Function.
Raptis V; Bakogiannis C; Loutradis C; Boutou AK; Lampropoulou I; Intzevidou E; Sioulis A; Balaskas E; Sarafidis PA
Am J Nephrol; 2018; 47(4):231-238. PubMed ID: 29597186
[TBL] [Abstract][Full Text] [Related]
24. Could Endocan, a Marker of Inflammation and Endothelial Dysfunction, be a New Diagnostic Marker for Fibromyalgia?
Mertoglu C; Gunay M; Yerligok O
Clin Lab; 2018 Mar; 64(3):405-410. PubMed ID: 29739097
[TBL] [Abstract][Full Text] [Related]
25. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
[TBL] [Abstract][Full Text] [Related]
26. Endocan: a new marker of endothelial function.
Balta S; Balta I; Mikhailidis DP
Curr Opin Cardiol; 2021 Jul; 36(4):462-468. PubMed ID: 33929364
[TBL] [Abstract][Full Text] [Related]
27. Predictive role of circulating endothelial-derived microparticles in cardiovascular diseases.
Berezin A; Zulli A; Kerrigan S; Petrovic D; Kruzliak P
Clin Biochem; 2015 Jun; 48(9):562-8. PubMed ID: 25697107
[TBL] [Abstract][Full Text] [Related]
28. Analysis of Serum Endothelial Cell-Specific Molecule 1 (Endocan) Level in Type 2 Diabetes Mellitus With Acute ST-Segment Elevation Myocardial Infarction and its Correlation: A Pilot Study.
Qiu CR; Fu Q; Sui J; Zhang Q; Wei P; Wu Y; Zhu K; Lu Y; Wan P
Angiology; 2017 Jan; 68(1):74-78. PubMed ID: 26927690
[TBL] [Abstract][Full Text] [Related]
29. Endocan and Erectile Dysfunction.
Balta S; Mikhailidis DP
Am J Mens Health; 2019; 13(6):1557988319893889. PubMed ID: 31829075
[TBL] [Abstract][Full Text] [Related]
30. Endothelial microparticles: missing link in endothelial dysfunction?
Yong PJ; Koh CH; Shim WS
Eur J Prev Cardiol; 2013 Jun; 20(3):496-512. PubMed ID: 22496273
[TBL] [Abstract][Full Text] [Related]
31. Endocan: A novel biomarker for risk stratification, prognosis and therapeutic monitoring in human cardiovascular and renal diseases.
Bessa J; Albino-Teixeira A; Reina-Couto M; Sousa T
Clin Chim Acta; 2020 Oct; 509():310-335. PubMed ID: 32710940
[TBL] [Abstract][Full Text] [Related]
32. Endothelial dysfunction: methods of assessment & implications for cardiovascular diseases.
Butt M; Dwivedi G; Blann A; Khair O; Lip GY
Curr Pharm Des; 2010; 16(31):3442-54. PubMed ID: 20858188
[TBL] [Abstract][Full Text] [Related]
33. Serum endocan levels are correlated with the presence and severity of coronary artery disease in patients with hypertension.
Wang XS; Yang W; Luo T; Wang JM; Jing YY
Genet Test Mol Biomarkers; 2015 Mar; 19(3):124-7. PubMed ID: 25588082
[TBL] [Abstract][Full Text] [Related]
34. Role of Microparticles in Cardiovascular Disease: Implications for Endothelial Dysfunction, Thrombosis, and Inflammation.
Lugo-Gavidia LM; Burger D; Matthews VB; Nolde JM; Galindo Kiuchi M; Carnagarin R; Kannenkeril D; Chan J; Joyson A; Herat LY; Azzam O; Schlaich MP
Hypertension; 2021 Jun; 77(6):1825-1844. PubMed ID: 33979187
[TBL] [Abstract][Full Text] [Related]
35. Circulating microparticles in cardiovascular disease: going on stage!
Fernández M; Calligaris SD
Biomarkers; 2019 Jul; 24(5):423-428. PubMed ID: 31068021
[No Abstract] [Full Text] [Related]
36. Evolving role of microparticles in the pathophysiology of endothelial dysfunction.
Lovren F; Verma S
Clin Chem; 2013 Aug; 59(8):1166-74. PubMed ID: 23529703
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the associations between endothelial dysfunction, inflammation and coagulation in Crimean-Congo hemorrhagic fever patients.
Doğan HO; Büyüktuna SA; Kapancik S; Bakir S
Arch Virol; 2018 Mar; 163(3):609-616. PubMed ID: 29159591
[TBL] [Abstract][Full Text] [Related]
38. Endocan Concentration in Kidney Transplant Recipients.
Malyszko J; Koc-Żórawska E; Malyszko JS
Transplant Proc; 2018; 50(6):1798-1801. PubMed ID: 30056903
[TBL] [Abstract][Full Text] [Related]
39. Towards a comprehensive endothelial biomarkers profiling and endothelium-guided pharmacotherapy.
Walczak M; Suraj J; Kus K; Kij A; Zakrzewska A; Chlopicki S
Pharmacol Rep; 2015 Aug; 67(4):771-7. PubMed ID: 26321280
[TBL] [Abstract][Full Text] [Related]
40. Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome.
Bicer M; Guler A; Unal Kocabas G; Imamoglu C; Baloglu A; Bilgir O; Yuksel A; Bozkaya G; Calan M
Endocr Res; 2017 May; 42(2):145-153. PubMed ID: 27911121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
